Elite Stack 1 combines three of the most extensively characterized selective androgen receptor modulators in the preclinical literature, spanning full and partial AR agonism. This bundled research option provides all three compounds as high-purity liquid solutions for structured laboratory use.
RAD-140 (Testolone) — 10mg/mL 30mL Non-steroidal AR full agonist. Documented tissue-selective activity in skeletal muscle and bone in preclinical models. High oral bioavailability. Frequently referenced in AR binding and neuroprotection pathway research.
LGD-4033 (Ligandrol) — 10mg/mL 30mL Non-steroidal AR full agonist with the highest binding affinity among characterized SARMs in published literature. Phase I clinical pharmacokinetic data available. Used in AR selectivity, anabolic pathway, and HPG axis modulation research.
MK-2866 (Ostarine) — 25mg/mL 30mL Non-steroidal AR partial agonist. The most extensively studied SARM in published clinical research, with Phase II trial data available. Frequently referenced in lean mass, bone density, and AR tissue selectivity studies.
Research Applications Comparative AR agonism across full and partial binders, binding affinity analysis, tissue selectivity studies, multi-compound interaction modeling.
Specifications Form: Lab-grade liquid solution · Volume: 30mL each · COA: Third-party verified · Storage: Cool, dry, away from light · Ships same day from Texas
For laboratory and preclinical research use only. Not for human or veterinary consumption.
Tien Wang (verified owner) –